21 Interstitial Cystitis Clinical Trials in Aurora, IL (2026)

Q: Are there interstitial cystitis clinical trials in Aurora?

Yes, there are 21 interstitial cystitis clinical trials currently recruiting in Aurora, IL.

Q: How do I join a clinical trial in Aurora?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you.

Q: Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Interstitial Cystitis Studies in Aurora

NCT01522183Recruiting

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Post-marketing safety data on patients treated and untreated with eculizumab or ravulizumab....

Aurora, IL3,000 participantsAlexion Pharmaceuticals, Inc.

View Study Details

NCT06578195Recruiting

ASSESS ALL ALS Study

The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS ge...

Aurora, IL2,000 participantsSt. Joseph's Hospital and Medical Center, Phoenix

View Study Details

NCT07280065Recruiting

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

The goal of the REVEAL PTSD study is to test how well the Senseye DT works as a diagnostic test for Post-traumatic Stress Disorder (PTSD) in adults 18 and older who are experiencing one or more sympto...

Aurora, ILPHASE31,900 participantsSenseye, Inc.

View Study Details

NCT06087029Recruiting

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic com...

Aurora, ILNA1,100 participantsDuke University

View Study Details

NCT06961214Recruiting

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab compared as an add-on medicine in ...

Aurora, ILPHASE3960 participantsGlaxoSmithKline

View Study Details

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using dat...

Aurora, IL750 participantsBoston Children's Hospital

View Study Details

NCT06863129Recruiting

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

The goal of this clinical trial is to find out if removing and replacing part of the hip bone works better than using metal hardware to stabilize the bone in patients whose cancer has spread to the hi...

Aurora, ILNA334 participantsMichelle Ghert, MD

View Study Details

NCT07078383Recruiting

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

The Goal of this Clinical Study is to evaluate the safety and effectiveness of the Rapidlink device in the repair or replacement of the supra-aortic vessels during open surgical repair of aortic disea...

Aurora, ILNA150 participantsVascutek Ltd.

View Study Details

NCT02998710Recruiting

Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)

The purpose of the study is to characterize the clinical course of homocystinuria in pediatric and adult patients aged 1 to 65 years under current clinical management practices...

Aurora, IL150 participantsTravere Therapeutics, Inc.

View Study Details

NCT06576271Recruiting

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

This study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active SLE (Part B), healthy pa...

Aurora, ILPHASE1142 participantsGlaxoSmithKline

View Study Details

NCT06582875Recruiting

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

The proposed clinical trial aims to assess if a year of treatment with a glucagon-like peptide 1 receptor agonist, a medication approved for weight management that also improves the body's response to...

Aurora, ILPHASE2126 participantsUniversity of Colorado, Denver

View Study Details

NCT07080242Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroen...

Aurora, ILPHASE1120 participantsSystImmune Inc.

View Study Details

NCT04911491Recruiting

Inspiratory Muscle Strength Training in Chronic Kidney Disease

More than 80% of individuals with chronic kidney disease have concomitant hypertension and the majority fail to achieve blood pressure control \<130/80 mmHg, leading to high risk of cardiovascular dis...

Aurora, ILNA108 participantsUniversity of Colorado, Denver

View Study Details

NCT06919692Recruiting

Maternal Left Lateral Position in Fetal Growth Restriction

The goal of this clinical trial is to learn if maternal left-lateral positioning in pregnancy works to treat fetal growth restriction. This study will also help us learn about the effects of left-late...

Aurora, ILNA100 participantsUniversity of Colorado, Denver

View Study Details

NCT07534358Recruiting

Intensive Case Management Between VA and Community Care for Suicide Prevention

The goal of this randomized clinical trial is to build the evidence base for SUPERCEDE, a suicide prevention focused intensive case management intervention to increase access, improve care coordinatio...

Aurora, ILNA100 participantsVA Eastern Colorado Health Care System

View Study Details

NCT06191640Recruiting

Sinus Disease in Young Children With Cystic Fibrosis

This is a prospective, observational study examining the impact of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators on chronic rhinosinusitis (CRS) and olfactory ...

Aurora, IL80 participantsUniversity of California, Los Angeles

View Study Details

NCT07085104Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

This is a first-in-human, single-arm, open-label study evaluating the safety, tolerability, and preliminary efficacy of ALLO-329 in adults with autoimmune diseases: systemic lupus erythematosus (SLE) ...

Aurora, ILPHASE166 participantsAllogene Therapeutics

View Study Details

NCT05909761Recruiting

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

This is an observational study to monitor female participants exposed to UPLIZNA during pregnancy. This study requires voluntary reporting of pregnancies in female participants with NMOSD exposed to U...

Aurora, IL60 participantsAmgen

View Study Details

NCT05711615Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

This phase I trial tests the safety, side effects, and best dose of combination therapy with liposomal doxorubicin and peposertib in treating patients with sarcoma that has spread from where it first ...

Aurora, ILPHASE130 participantsNational Cancer Institute (NCI)

View Study Details

NCT07252050Recruiting

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

This trial will determine whether adding ruxolitinib to a reduced intensity conditioning (RIC) regimen reduces the rate of graft failure following haploidentical (haplo) hematopoietic cell transplant ...

Aurora, ILPHASE124 participantsArkansas Children's Hospital Research Institute

View Study Details

NCT07112378Recruiting

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

This study is researching an experimental drug called dupilumab (called "study drug"). The study is focused on children with active eosinophilic esophagitis (EoE; an inflammatory disease of the esopha...

Aurora, ILPHASE320 participantsRegeneron Pharmaceuticals

View Study Details

About Interstitial Cystitis Clinical Trials in Aurora

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 21 interstitial cystitis clinical trials recruiting participants in Aurora, IL. These studies are seeking a combined 11,320 participants. Research is being sponsored by Alexion Pharmaceuticals, Inc., St. Joseph's Hospital and Medical Center, Phoenix, Senseye, Inc. and 15 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Aurora — FAQ

Are there interstitial cystitis clinical trials in Aurora?

Yes, there are 21 interstitial cystitis clinical trials currently recruiting in Aurora, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 21 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated August 29, 2026 from ClinicalTrials.gov